Galenica Sante AG (GALE) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Galenica Sante AG (GALE) has a cash flow conversion efficiency ratio of 0.129x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF190.83 Million ≈ $241.26 Million USD) by net assets (CHF1.49 Billion ≈ $1.88 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Galenica Sante AG (GALE) total market value for the company's overall valuation and market capitalisation.
Galenica Sante AG - Cash Flow Conversion Efficiency Trend (2014–2025)
This chart illustrates how Galenica Sante AG's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Galenica Sante AG Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Galenica Sante AG ranked by their cash flow conversion efficiency. Explore how high is Galenica Sante AG's earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
ESAB Corp
NYSE:ESAB
|
0.021x |
|
Persimmon Plc
F:OHP
|
-0.038x |
|
Adecco Group AG Class N
SW:ADEN
|
0.006x |
|
Acm Research Inc
NASDAQ:ACMR
|
-0.014x |
|
Hamilton Lane Inc
NASDAQ:HLNE
|
0.056x |
|
Premier Inc
NASDAQ:PINC
|
0.010x |
|
Emcure Pharmaceuticals Ltd
NSE:EMCURE
|
0.051x |
|
PBF Energy Inc
NYSE:PBF
|
0.005x |
Annual Cash Flow Conversion Efficiency for Galenica Sante AG (2014–2025)
The table below shows the annual cash flow conversion efficiency of Galenica Sante AG from 2014 to 2025. View current stock price of Galenica Sante AG for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CHF1.49 Billion ≈ $1.88 Billion |
CHF299.76 Million ≈ $378.98 Million |
0.202x | +18.34% |
| 2024-12-31 | CHF1.55 Billion ≈ $1.96 Billion |
CHF264.70 Million ≈ $334.66 Million |
0.171x | +11.48% |
| 2023-12-31 | CHF1.48 Billion ≈ $1.87 Billion |
CHF225.71 Million ≈ $285.36 Million |
0.153x | -19.29% |
| 2022-12-31 | CHF1.25 Billion ≈ $1.58 Billion |
CHF236.87 Million ≈ $299.47 Million |
0.190x | -29.79% |
| 2021-12-31 | CHF1.23 Billion ≈ $1.56 Billion |
CHF333.10 Million ≈ $421.12 Million |
0.270x | +26.76% |
| 2020-12-31 | CHF1.05 Billion ≈ $1.33 Billion |
CHF224.36 Million ≈ $283.65 Million |
0.213x | -14.99% |
| 2019-12-31 | CHF999.54 Million ≈ $1.26 Billion |
CHF250.44 Million ≈ $316.62 Million |
0.251x | +34.78% |
| 2018-12-31 | CHF933.60 Million ≈ $1.18 Billion |
CHF173.55 Million ≈ $219.41 Million |
0.186x | +10.91% |
| 2017-12-31 | CHF861.51 Million ≈ $1.09 Billion |
CHF144.40 Million ≈ $182.56 Million |
0.168x | -64.28% |
| 2016-12-31 | CHF334.20 Million ≈ $422.53 Million |
CHF156.82 Million ≈ $198.26 Million |
0.469x | -8.17% |
| 2015-12-31 | CHF259.19 Million ≈ $327.69 Million |
CHF132.44 Million ≈ $167.43 Million |
0.511x | +45.94% |
| 2014-12-31 | CHF240.26 Million ≈ $303.76 Million |
CHF84.12 Million ≈ $106.35 Million |
0.350x | -- |
About Galenica Sante AG
Galenica AG provides healthcare services in Switzerland and internationally. It operates through two segments, Products & Care, and Logistics & IT. The Products & Care segment operates and manages pharmacies and partner pharmacies under the Amavita, Sun Store, and Coop Vitality brands, as well as covers specialty pharmacy mediservice. This segment also offers medication for treatment of patients … Read more